Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001061499 | SCV001226243 | likely benign | Epilepsy, familial adult myoclonic, 5 | 2023-11-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004031961 | SCV003873357 | uncertain significance | not specified | 2023-02-15 | criteria provided, single submitter | clinical testing | The c.2037G>A (p.M679I) alteration is located in exon 16 (coding exon 15) of the CNTN2 gene. This alteration results from a G to A substitution at nucleotide position 2037, causing the methionine (M) at amino acid position 679 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |